Vitamin E and selenium supplementation is unlikely to impact the progression of age-related cataracts in men, as suggested by previous research, according to a study published in JAMA Ophthalmol.
Aker BioMarine Antarctic has been given product approval for its Superba krill oil by the Indian regulators.
Olive and coconut oils may improve the intestinal absorption of lutein, according to research in mice.
Fuji Chemical-owned astaxanthin specialist AstaReal has emphasised differences in the types of the carotenoid not accounted for in a recent EFSA refusal to back intakes at 4 mg a day in the European Union.
The European Union chief science agency has failed to back astaxanthin consumption at levels over 4 mg astaxanthin per day after responding to a novel foods application from Japanese player, Fuji Chemical-owned AstaReal.
An early form of the eye condition age-related macular degeneration (AMD) can occur in people as young as 35, according to German researchers.
Two years ago lutein player Kemin said it was, “baffled and annoyed” when EFSA rejected its eye health claim that was already approved in France. This week the EU’s food science agency has done it again, but Kemin and its lutein partner DSM, say they are unperturbed and will, “continue to invest in science”.
Daily supplements containing Chlorella may reduce cholesterol and triglyceride levels in people with mildly elevated cholesterol levels, says a new study from Korea.
Supplementing lactating women with lutein is an effective way of raising the lutein status of the breast-feeding infant, says a new study from Abbott Nutrition with potential implications for eye and cognitive health of children.
Supplements firm Pharma Marine has won Marine Steward Council (MSC) Chain of Custody standard for its by-product ingredient line CodMarine, but it’s critical other supplement players follow suit in addressing their sizable marine footprint, says the certification body.
A response published today in the Annals of Internal Medicine by four well-known nutrition researchers takes strident issue with an editorial published in the same journal that multivitamins are not useful. The authors of the first paper “ignored decades of nutrition research and diet monitoring of the U.S. population to reach this misleading conclusion,” the researchers wrote.
Carotenoids like lutein are well-documented to boost eye health yet the approach of the medical fraternity and some regulators lacks vision when it comes to prevention, says a leading professor in the area.
It’s a controversial topic with the science still emerging but is an inadequate understanding and premature conclusions clouding the potential of meso-zeaxanthin?
Despite a substantial body of science supporting the eye health of lutein, a DRI (dietary reference intakes) for lutein is still many years away, say experts.
Medical gum firm Fertin Pharma has teamed with DSM to develop a Vision Gum in the ‘under-exploited’ eye health category.
The meso-zeaxanthin cartenoid is a synthetic, quasi pharmaceutical that needs holistic research on whole body affects, says an eye health researcher.
The eye health benefits of astaxanthin will steadily increase demand for this already red-hot ingredient, says Rudi Moerck, PhD, CEO of Valensa, one of the major suppliers. This benefit is tied into an aging demographic; few younger consumers think about prophylatic eye care.
The discourse around eye health carotenoid meso-zeaxanthin (MZ) has been marred by commercial interests, according to supplement firm OmniActive Health Technologies.
In 2012 there were over 577 million people aged over 65 globally, but there remains a 7-year gap between life expectancy and healthy life expectancy, according to a Euromonitor analyst.
Last week’s UK ruling that health claims made on Ribena’s website were ‘exaggerated’ suggests there is not as much flexibility as the industry might have hoped when it comes to rewording authorised health claims to make them more understandable to consumers, according to legal experts.